XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business AchievementsDoubled the royalty and milestone portfolio to over 120 royalty assets with significant milestone potential through five transactions in 2024
XOMA Royalty to Present at Investor Conferences in MarchEMERYVILLE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (
NASDAQXOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the following investor conferences in March. Management will also participate in one-on-one investor meetings.
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences ConferenceEMERYVILLE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (
NASDAQXOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the Oppenheimer 35th Annual Healthcare Life Sciences Conference being held virtually, February 11-12, 2025.
